(1 - 9 von 13
)
Crescendo Biologics Announces Humabody Evaluation in CAR-T by Takeda
www.finanznachrichten.de
Dr Peter Pack, CEO of Crescendo, commented: "We're pleased to see the research Takeda is undertaking with our Humabody technology.
Crescendo Biologics appoints new Chief Business Officer
www.bionity.com
Dr. Peter Pack, CEO of Crescendo Biologics commented: “Crescendo's platform is delivering a robust pipeline of intrinsically differentiated, ...
Crescendo Biologics Appoints Philip Bland-Ward as Chief Scientific...
sofinnovapartners.com
Dr Peter Pack, CEO of Crescendo Biologics, said: “Over the past 24 months, Crescendo has transitioned from a technology platform company ...
Crescendo Biologics Reaches Technical Milestone for a Second Target...
apnews.com
Dr Peter Pack, CEO of Crescendo, commented: “Crescendo has once again demonstrated its ability to deliver, ahead of schedule, a diverse ...
sortiert nach Relevanz / Datum